Press release Tests prove Sona’s gold nanorods “perfectly suited” for competitive lateral flow assays Sona Nanotech’s unique gold nanorods are perfectly suited for use in competitive lateral flow assays, a new report reveals. A white paper, published by Sona Nanotech
Diagnostics companies sign new commercial agreement to address limitations in development of multiplex point-of-care lateral flow assay diagnostic tests Halifax, Nova Scotia–(Newsfile Corp. – August 6, 2019) – Sona Nanotech Inc. (CSE: SONA) and Expedeon AG (FSE: EXN) (ISIN: DE000A1RFM03),
Sona wins Startup Canada Innovation Award Halifax, NS – 11th June 2019 – Dartmouth-based life sciences company Sona Nanotech Inc. has been named the Startup Canada Innovation Award winner for the Atlantic Canada region. The company, which produces microscopic gold
Halifax, Nova Scotia–(Newsfile Corp. – May 9, 2019) – Sona Nanotech Inc.’s (CSE: SONA) mission to advance medical diagnostics took a step forward today with the announcement of a collaboration with the University of Birmingham in the UK to develop
Halifax, Nova Scotia–(Newsfile Corp. – March 12, 2019) – Sona Nanotech Inc. (CSE: SONA) has signed a collaboration agreement with a UK medical diagnostics company to develop new highly sensitive point of care diagnostic tests for infectious diseases. OLM Diagnostics,
Halifax, Nova Scotia–(Newsfile Corp. – March 7, 2019) – Sona Nanotech Inc. (CSE: SONA) today announced a collaboration with global diagnostics solutions provider Romer Labs to improve performance in their RapidChek® SELECT™ pathogen test kits. With over 30 years of
January 21, 2019 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA) (the “Company”) is pleased to announce that it has granted 1,410,000 incentive stock options under the Company’s Stock Option Plan (“Option Plan”) of which 850,000 have been granted
Innovative companies combine technologies to speed up lateral flow assay development time Halifax, Nova Scotia–(Newsfile Corp. – January 16, 2019) – Sona Nanotech Inc. (CSE: SONA) today announced a collaboration with Australia-based nanotech company Anteo Technologies Pty Ltd to speed
Sona Nanotech Inc., an innovative Nova Scotian life sciences company, has opened new laboratory facilities in Halifax after a year of rapid growth. The company manufactures unique gold nanoparticles shaped like rods for use in diagnostic tests and other healthcare
Halifax, Nova Scotia–(Newsfile Corp. – December 4, 2018) – Sona Nanotech Inc. (CSE: SONA) has signed a collaboration agreement with one of Europe’s largest lateral flow test developers, who will integrate Sona’s nanorod technology into their market-established lateral flow assays.
Halifax, Nova Scotia–(Newsfile Corp. – November 22, 2018) – Sona Nanotech Inc. (CSE: SONA) has relocated its laboratory facilities to Halifax as it seeks to capitalise on recent business success and further expand its business in the diagnostics market. Following
Halifax, Nova Scotia, November 08, 2018 – Sona Nanotech Inc. (CSE: SONA) has engaged the services of a leading expert in gold and nanotechnology to help develop its business proposition in Europe. UK-based consultant Trevor Keel has a degree in
Halifax, Nova Scotia, October 25, 2018 –Sona Nanotech Inc. (CSE: SONA) today announcedit has signed a co-marketing agreement with UK-based digital healthcare company Bond Digital Health. The agreement means the two companies will work together to market and promote each
Sona Nanotech Inc. Gemini Nanorods to be assessed for increasing performance of marketed lateral flow tests and development of new-to-market lateral flow tests. Halifax, Nova Scotia, October 17, 2018 –Sona Nanotech Inc. (CSE:SONA)today announced a collaboration with Soma BioScience (Soma)
Halifax, Nova Scotia, October 11, 2018 – Sona Nanotech Inc. (CSE: SONA) today announced the signing of an agreement with global biotech company Expedeon Ltd. (FSE: EXN) for the supply of Sona’s unique gold nanorods for integration into Expedeon’s product
Halifax, Nova Scotia, October 3, 2018 – Sona Nanotech Inc. (CSE: SONA) (“Sona” or the “Company”) is pleased to announce that the Canadian Securities Exchange (CSE) has approved the Company’s application to list its common shares on the CSE. Effective
Stockport Exploration Inc. and Sona Nanotech Ltd. have completed their amalgamation to form Sona Nanotech Inc., the final step before the company can list on the Canadian Securities Exchange. Sona has also reduced the pricing of the previously private placement
The Canadian Securities Exchange (CSE) has given conditional listing approval for Sona Nanotech. It follows the approval of the merger between Stockport Exploration Inc. and Sona Nanotech, which was agreed by shareholders of the two companies at their general meetings on April
Sona Nanotech has appointed a business development manager to help the company forge new strategic partnerships and expand into new markets. The newly-created role has been given to Anindita Gupta, who has more than nine years’ experience in biological sciences
Sona Nanotech is to receive $500,000 in funding from the Atlantic Canada Opportunities Agency (ACOA) to help it commercialize its products and services, it was announced today. The repayable investment was announced by Darren Fisher, Member of Parliament for Dartmouth
Shareholders of Stockport Exploration voted 99 percent in favour of merging with Sona Nanotech at an annual and special general meeting last night. The meeting, held at the Numus Financial Offices in Purdy’s Wharf, Halifax, was attended by 18 investors, as well as employees
